Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

11.75
Delayed Data
As of Feb 24
 +0.05 / +0.43%
Today’s Change
9.59
Today|||52-Week Range
17.55
-13.28%
Year-to-Date
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb 17 / Zacks.com - Paid Partner Content
Prothena (PRTA) Reports Wider-than-Expected Loss in Q4
Feb 15 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb 16 / Zacks.com - Paid Partner Content
Gilead (GILD) Announces Data on Combination Therapy for HIV
Feb 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close11.70
Today’s open11.55
Day’s range11.53 - 12.00
Volume629,980
Average volume (3 months)941,482
Market cap$538.6M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+151.72%
Earnings growth (this year)+27.38%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+32.68%
P/E ratio40.5
Price/Sales5.16
Price/Book6.19

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.14+2.87%
ESPREsperion Therapeutic...-0.08-0.33%
ENTAEnanta Pharmaceutica...-0.25-0.89%
ACHNAchillion Pharmaceut...-0.38-8.96%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)$0.48
Annual revenue (last year)$153.2M
Annual profit (last year)$33.4M
Net profit margin21.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Andrew P. Smith
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs